Cargando…

Changes of Mental State and Serum Prolactin Levels in Patients with Schizophrenia and Depression after Receiving the Combination Therapy of Amisulpride and Chloroprothixol Tablets

OBJECTIVE: To investigate the changes in mental state and serum prolactin levels in patients with schizophrenia and depression after receiving the combination therapy of amisulpride and chloroprothixol tablets. METHODS: A total of 148 schizophrenic patients with depression were randomly divided into...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Bozhi, Yuan, Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888067/ https://www.ncbi.nlm.nih.gov/pubmed/35242209 http://dx.doi.org/10.1155/2022/6580030

Ejemplares similares

Retracted: Changes of Mental State and Serum Prolactin Levels in Patients with Schizophrenia and Depression after Receiving the Combination Therapy of Amisulpride and Chloroprothixol Tablets
por: Methods in Medicine, Computational and Mathematical
Publicado: (2022)

Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia
por: Liu, Jin-Ling, et al.
Publicado: (2023)

Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Mortimer, Ann M
Publicado: (2009)

PM391. THE USE OF AMISULPRIDE IN TREATMENT OF PATIENTS WITH RESIDUAL SCHIZOPHRENIA
por: Janjic, Vladimir, et al.
Publicado: (2016)

A cost-utility analysis of Amisulpride and Paliperidone in the treatment of Schizophrenia
por: Abdall-Razak, Ali, et al.
Publicado: (2019)

Hyperprolactinaemia with amisulpride
por: Raj, Rajnish, et al.
Publicado: (2008)

SERUM PROLACTIN LEVEL AND SEVERITY OF PSYCHOPATHOLOGY IN PATIENTS OF SCHIZOPHRENIA
por: Shrivastava, Amresh, et al.
Publicado: (2000)

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE
por: Drosos, Petros, et al.
Publicado: (2020)

Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders
por: de Haan, Lieuwe, et al.
Publicado: (2023)

Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis
por: Zangani, Caroline, et al.
Publicado: (2021)

Amisulpride induced mania
por: Aggarwal, Ashish, et al.
Publicado: (2010)

Analysis of Gut Microbiota in Patients with Exacerbated Symptoms of Schizophrenia following Therapy with Amisulpride: A Pilot Study
por: Zheng, Jinchi, et al.
Publicado: (2022)

Amisulpride Reexposure and Tardive Dyskinesia
por: Sidana, Ajeet
Publicado: (2018)

Population pharmacokinetics of Amisulpride in Chinese patients with schizophrenia with external validation: the impact of renal function
por: Li, Anning, et al.
Publicado: (2023)

Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia
por: Yang, Fuyin, et al.
Publicado: (2018)

Serum Prolactin and Bone Mineral Density in Schizophrenia: A Systematic Review
por: Lally, John, et al.
Publicado: (2019)

The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open- label study
por: Herrera-Estrella, Miguel, et al.
Publicado: (2005)

Effect of Peony-Glycyrrhiza Decoction on Amisulpride-Induced Hyperprolactinemia in Women with Schizophrenia: A Preliminary Study
por: Yang, Ping, et al.
Publicado: (2017)

Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial
por: Barnes, Thomas R.E., et al.
Publicado: (2018)

Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study
por: Liang, Ying, et al.
Publicado: (2017)

Rechallenge with Amisulpride in a Patient with Schizophrenia following a Manic Episode during Previous Therapy
por: Hu, Li-Yu, et al.
Publicado: (2022)

Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia
por: Hu, Ze-Rui, et al.
Publicado: (2022)

The use of amisulpride in the treatment of acute psychosis
por: Nuss, Philippe, et al.
Publicado: (2007)

Safety and tolerability of antipsychotics: focus on amisulpride
por: Juruena, Mario F, et al.
Publicado: (2010)

Delayed-onset akathisia due to amisulpride
por: Atmaca, Murad, et al.
Publicado: (2011)

Treatment of Burning Mouth Syndrome With Amisulpride
por: Rodriguez-Cerdeira, Carmen, et al.
Publicado: (2012)

Tardive dyskinesia with low dose amisulpride
por: Tharoor, Hema, et al.
Publicado: (2013)

SERUM PROLACTIN LEVELS IN SCHIZOPHRENIA: EFFECTS OF NEUROLEPTIC MEDICATION - A PRELIMINARY STUDY
por: Kuruvilla, K., et al.
Publicado: (1986)

Prolactin and Family Psychiatric History in Schizophrenia
por: Bouguerra, I., et al.
Publicado: (2023)

Serum prolactin and migraine
por: Masoud, S. Ali, et al.
Publicado: (2005)

Metformin in the Treatment of Amisulpride-Induced Hyperprolactinemia: A Clinical Trial
por: Zhu, Cuifang, et al.
Publicado: (2022)

Clinical Usefulness of Amisulpride Add-on Therapy in Schizophrenia Patients without Treatment Response to Second-generation Antipsychotics
por: Kang, Seung-Gul, et al.
Publicado: (2021)

The use of amisulpride in schizophrenic patients with resistant symptomatology
por: Kalfas, Dimitrios, et al.
Publicado: (2010)

Ejaculatory dysfunction associated with low dose amisulpride
por: Nagapurkar, Umesh, et al.
Publicado: (2013)

Extrapyramidal side effects with low doses of amisulpride
por: Mandal, Nikhiles, et al.
Publicado: (2014)

Amisulpride withdrawal dyskinesia: a case report
por: Lo, Yu-Chi, et al.
Publicado: (2017)

Prolactin levels and agressive behaviour in men with Schizophrenia
por: Bouguerra, I., et al.
Publicado: (2023)

Levosulpiride and Serum Prolactin Levels
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2017)

Topiramate add-on treatment associated with normalization of prolactin levels in a patient with schizophrenia
por: Huang, Yinglin, et al.
Publicado: (2017)

Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial
por: Leweke, F. Markus, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9jkjmjcrs9ts3vtm1jkmlkvsmq